Status:
RECRUITING
French Clinical Datbase of Melanoma Patients (RIC-Mel)
Lead Sponsor:
Nantes University Hospital
Collaborating Sponsors:
CENGEPS
Bristol-Myers Squibb
Conditions:
Melanoma (Skin)
Eligibility:
All Genders
18+ years
Brief Summary
With a high incidence, low survival rates and limiter availability of effective treatment, melanoma is one of the research priorities for health authorities. Optimizing the development of both academi...
Detailed Description
The RIC-Mel network federate clinicians researchers working in clinical and translational research for melanoma and carrying out patients inclusions in the clinical trials. These clinicians are workin...
Eligibility Criteria
Inclusion
- Patient with melanoma, of any stage,
- Patient agreed to participate.
Exclusion
- Individuals under court protection
Key Trial Info
Start Date :
March 1 2012
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 1 2030
Estimated Enrollment :
16000 Patients enrolled
Trial Details
Trial ID
NCT03315468
Start Date
March 1 2012
End Date
March 1 2030
Last Update
July 22 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Nantes University Hospital
Nantes, France, 44093